hCdc14A and its Role in Cancer
Author Information
Author(s): Michelle T. Paulsen, Adrienne M. Starks, Frederick A. Derheimer, Sheela Hanasoge, Li Liwu, Jack E. Dixon, Mats Ljungman
Primary Institution: University of Michigan Comprehensive Cancer Center
Hypothesis
Does the human phosphatase hCdc14A interact with the Cdk1/cyclin B complex and vary in expression across different human cancers?
Conclusion
hCdc14A is differentially expressed in human cancer cells and interacts with both p53 and the Cdk1/cyclin B complex, suggesting its dysregulation may contribute to cancer development.
Supporting Evidence
- hCdc14A is differentially expressed in 75 cancer cell lines.
- High expression of hCdc14A is rarely found in tumors with wild-type p53.
- hCdc14A interacts with Cdk1/cyclin B during interphase.
Takeaway
hCdc14A is a protein that behaves differently in cancer cells, and it can affect another important protein called p53, which helps control cell growth.
Methodology
Antibodies against hCdc14A were developed to study its expression in human tissues and cancer cell lines, with various treatments applied to assess expression levels.
Limitations
The study does not explore the functional consequences of hCdc14A dysregulation in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website